Subsequent Events (Tables)

3 Months Ended

Mar. 31, 2014

Share-based Compensation options granted

The following table describes the details of the options granted:

	Grant	Strike	Number of
	Date	Price	Options Granted
Chris Rallis	April 25, 2014	0.77	12,987
Steven Skolsky	April 25, 2014	0.77	12,987
Adrian Haigh	April 25, 2014	0.77	400,000	(1)
Dr. Khalid Islam	April 25, 2014	0.77	400,000	(1)

Total options granted			825,974

(1) Such options shall vest: (i) as to 200,000 Common Shares, on the date of grant; and (ii) as to 200,000 Common Shares, upon and subject to orphan drug approval of STS in the EU, provided that they then remain on the Board at the time of such approval and that they have played a vital or precipitating part in obtaining such EU orphan drug designation, as reasonably determined by non-interested Board members. If the vesting conditions referred to in (ii) above have not occurred by May 31, 2016, the option to acquire the 200,000 common shares referred to in (ii) above shall be terminated and of no further force or effect.